Cargando…
Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey
Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment practices in different settings for four implantation mycoses: eumycetoma, actinomycetoma, cutaneous sporotrichosis and chromoblastomycosis. The survey investigated the type of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335693/ https://www.ncbi.nlm.nih.gov/pubmed/37379338 http://dx.doi.org/10.1371/journal.pntd.0011443 |
_version_ | 1785071052842336256 |
---|---|
author | Milani, Barbara Dagne, Daniel Argaw Choi, Hye Lynn Schito, Marco Stone, Heather Anne |
author_facet | Milani, Barbara Dagne, Daniel Argaw Choi, Hye Lynn Schito, Marco Stone, Heather Anne |
author_sort | Milani, Barbara |
collection | PubMed |
description | Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment practices in different settings for four implantation mycoses: eumycetoma, actinomycetoma, cutaneous sporotrichosis and chromoblastomycosis. The survey investigated the type of diagnostic methods available in countries at various health system levels (tertiary, secondary, primary level) and the medicines used to treat implantation mycoses, with a view to understanding the level of drug repurposing for treatment of these diseases. 142 respondents from 47 countries, including all continents, contributed data: 60% were from middle-income countries, with 59% working at the tertiary level of the health system and 30% at the secondary level. The results presented in this article provide information on the current diagnostic capacity and treatment trends for both pharmacological and non-pharmacological interventions. In addition, the survey provides insight on refractory case rates, as well as other challenges, such as availability and affordability of medicines, especially in middle-income countries. Although the study has limitations, the survey-collected data confirms that drug repurposing is occurring for all four surveyed implantation mycoses. The implementation of an openly accessible global and/or a national treatment registry for implantation mycoses could contribute to address the gaps in epidemiological information and collect valuable observational data to inform treatment guidelines and clinical research. |
format | Online Article Text |
id | pubmed-10335693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-103356932023-07-12 Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey Milani, Barbara Dagne, Daniel Argaw Choi, Hye Lynn Schito, Marco Stone, Heather Anne PLoS Negl Trop Dis Research Article Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment practices in different settings for four implantation mycoses: eumycetoma, actinomycetoma, cutaneous sporotrichosis and chromoblastomycosis. The survey investigated the type of diagnostic methods available in countries at various health system levels (tertiary, secondary, primary level) and the medicines used to treat implantation mycoses, with a view to understanding the level of drug repurposing for treatment of these diseases. 142 respondents from 47 countries, including all continents, contributed data: 60% were from middle-income countries, with 59% working at the tertiary level of the health system and 30% at the secondary level. The results presented in this article provide information on the current diagnostic capacity and treatment trends for both pharmacological and non-pharmacological interventions. In addition, the survey provides insight on refractory case rates, as well as other challenges, such as availability and affordability of medicines, especially in middle-income countries. Although the study has limitations, the survey-collected data confirms that drug repurposing is occurring for all four surveyed implantation mycoses. The implementation of an openly accessible global and/or a national treatment registry for implantation mycoses could contribute to address the gaps in epidemiological information and collect valuable observational data to inform treatment guidelines and clinical research. Public Library of Science 2023-06-28 /pmc/articles/PMC10335693/ /pubmed/37379338 http://dx.doi.org/10.1371/journal.pntd.0011443 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Milani, Barbara Dagne, Daniel Argaw Choi, Hye Lynn Schito, Marco Stone, Heather Anne Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey |
title | Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey |
title_full | Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey |
title_fullStr | Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey |
title_full_unstemmed | Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey |
title_short | Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey |
title_sort | diagnostic capacities and treatment practices on implantation mycoses: results from the 2022 who global online survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335693/ https://www.ncbi.nlm.nih.gov/pubmed/37379338 http://dx.doi.org/10.1371/journal.pntd.0011443 |
work_keys_str_mv | AT milanibarbara diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey AT dagnedanielargaw diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey AT choihyelynn diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey AT schitomarco diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey AT stoneheatheranne diagnosticcapacitiesandtreatmentpracticesonimplantationmycosesresultsfromthe2022whoglobalonlinesurvey |